Vertigo, a common and distressing clinical symptom, often presents a diagnostic challenge to healthcare professionals. It is characterized by a sensation of spinning or movement, either of self or surrounding objects. This article aims to provide a comprehensive clinical approach to vertigo, enabling physicians to better diagnose and manage this condition.
Vertigo is a symptom, not a disease, often resulting from a dysfunction in the vestibular system. Differentiating between peripheral and central causes is crucial as it significantly impacts the management and prognosis of the patient. Peripheral vertigo is more common and is usually benign, whereas central vertigo might indicate serious neurological conditions.
A thorough clinical history and physical examination form the cornerstone of vertigo evaluation. Key points to consider include onset, duration, frequency, and associated symptoms. The Dix-Hallpike maneuver and Head Impulse Test are valuable bedside tests for peripheral vertigo. Neurological examination and imaging may be required in cases suspected of central vertigo.
Management of vertigo is multifaceted, involving symptomatic treatment, vestibular rehabilitation, and addressing the underlying cause. Medications such as vestibular suppressants and antiemetics provide symptomatic relief. Vestibular rehabilitation exercises improve balance and reduce dizziness. In refractory cases or when a serious underlying condition is identified, specialist referral is warranted.
Vertigo is a complex symptom with a wide range of potential causes. A systematic clinical approach is essential to differentiate between peripheral and central vertigo, which is critical for appropriate management. By understanding the nuances of vertigo, healthcare professionals can improve patient outcomes through precise diagnosis and targeted treatment strategies.
1.
TCL1A Protein Identified as Predictor of Blinatumomab Response in Relapsed B-ALL
2.
Health researchers discuss Medicaid cancer screening trends, best practices
3.
Taking Charge of Your Cancer Journey.
4.
On all CAR-T products, the FDA is calling for a new boxed warning.
5.
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Breaking Down Leukocytoclastic Vasculitis: Causes, Symptoms and Treatment
3.
Getting to Know RDW and SD: How They Relate to Anemia, Inflammation, and More
4.
A Review on Genetic Predispositions and Clinical Advancements of Multiple Myeloma Cancer
5.
AI-Powered Rehabilitation: A Game Changer for Hemophilia Management
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
3.
Navigating the Complexities of Ph Negative ALL - Part II
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation